Table 3.
Summary of reports in the literature on endoscopic ultrasound-guided gastroenterostomy for malignant gastric outlet obstruction
|
Ref.
|
Nation
|
Study design
|
Population (n)
|
Techniques
|
Technical success (%)
|
Clinical success (%)
|
Adverse events(%)
|
Follow-up (wk)
|
GOO recurrence (%)
|
| Khashab et al[28], 2015 | United States | Retrospective multicenter | 10 (3 with malignant GOO) | Direct (n = 1). Balloon-assisted (n = 9) | 90 | 100 | 0 | 21 | 0 |
| Tyberg et al[29], 2016 | United States | Retrospective multicenter | 26 (17 with malignant GOO) | Direct (n = 3). Balloon-assisted (n = 13). NB catheter assisted (n = 3). Hybrid rendezvous (n = 5) | 92 | 88 | 11.5 | 8 | 0 |
| Itoi et al[30], 2016 | Japan | Prospective single center | 20 | EPASS | 90 | 90 | 10 | 14 | 0 |
| Brewer Gutierrez et al[31], 2017 | United States | Retrospective multicenter | 7 | Direct (n = 5). Balloon-assisted (n = 2) | 100 | 100 | 0 | 15 | 0 |
| Perez-Miranda et al[32], 2017 | United States and Europe | Retrospective multicenter | 25 (17 with malignant GOO) | Direct (n = 6). Balloon-assisted (n = 9). NB catheter assisted (n = 3). Ultraslim-endoscope assisted (n = 7) | 88 | 84 | 12 | 8 | 0 |
| Khashab et al[33], 2017 | United States and Japan | Retrospective multicenter | 30 | Direct (n = 2). Balloon-assisted (n = 6). EPASS (n = 22) | 87 | 87 | 16 | 22 | 3 |
| Chen et al[34], 2017 | United States and Japan | Retrospective multicenter | 30 | Direct (n = 2). Balloon-assisted (n = 6). EPASS (n = 22) | 86.7 | 83.3 | 16.7 | 14 | 4.3 |
| Chen et al[35], 2018 | United States and Europe | Retrospective multicenter | 77 (52 with malignant GOO) | Direct (n = 52). Balloon-assisted (n = 22) | 94.2 | 92.3 | 6.8 | 17 | 7 |
| 90.9 | 90.9 | 9 | |||||||
| Urrehman et al[36], 2018 | Singapore | Prospective single center | 5 | Balloon-assisted EUS-GE | 100 | 80 | 0 | - | - |
| Ge et al[37], 2019 | United States | Prospective single center | 22 | Direct EUS-GE | 100 | 95.8 | 20.8 | 24 | 4.5 |
| Kerdsirichairat et al[38], 2019 | United States | Retrospective multicenter | 57 (34 with malignant GOO) | Direct EUS-GE | 93 | 89.5 | 3.5 | 28 | 15.1 |
| Xu et al[39], 2020 | China | Retrospective single center | 36 | Double balloon-assisted EUS-GE | 100 | 94.4 | 25 | 13 | 2.7 |
| Hu et al[40], 2020 | China | Prospective single center | 9 | RPAT-assisted EUS-GE | 100 | 100 | - | - | - |
| Kastelijn et al[41], 2020 | Europe | Retrospective multicenter | 45 | Direct (n = 36). Balloon-assisted (n = 9) | 86.7 | 73.3 | 26.7 | 10 | 5.1 |
| Wannhoff et al[42], 2020 | Germany | Retrospective single center | 35 (33 with malignant GOO) | Direct (n = 22). Others (n = 12) | 80 | 74.3 | 14.3 | 8 | 10 |
GOO: Gastric outlet obstruction; NB: Nasobiliary; EUS-GE: Endoscopic ultrasound-guided gastroenterostomy; EPASS: EUS-guided double balloon-occluded gastrojejunostomy bypass; RPAT: Retrievable puncture anchor traction.